Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Surgery

• Publication date

  1999-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MSY.1999.98925PMID 10418589
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver complications of pediatric parenteral nutrition--epidemiology.

  1998cited by this paper
• Advances in nutrition and gastroenterology: summary of the 1997 A.S.P.E.N. Research Workshop.

  1998cited by this paper
• Nutrition support in clinical practice: review of published data and recommendations for future research directions. National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition.

  1997cited by this paper
• Nutrition support in clinical practice: review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition.

  1997cited by this paper
• Prevention of liver failure in parenteral nutrition-dependent children with short bowel syndrome.

  1997cited by this paper
• Nutrition support in clinical practice: review of published data and recommendations for future research directions.

  1997cited by this paper
• Determinants of plasma concentrations of insulin-like growth factor-I and albumin and their hepatic mRNAs: the role of dietary protein content and tumor necrosis factor in malnourished rats.

  1996cited by this paper
• The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer.

  1996cited by this paper
• Hepatocyte-derived interleukin-6 and tumor-necrosis factor alpha mediate the lipopolysaccharide-induced acute-phase response and nitric oxide release by cultured rat hepatocytes.

  1995cited by this paper
• Immunohistochemical demonstration of interleukin-1 beta induced changes in acute-phase proteins and albumin in rat liver.

  1995cited by this paper
• Choline deficiency: A cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation

  1995cited by this paper
• Warfarin and reduced central venous thrombosis in home total parenteral nutrition patients.

  1995cited by this paper
• Cytokines, the Acute‐Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer

  1994cited by this paper
• The Addition of Lipids Increases the Total Parenteral Nutrition-Associated Cholestasis in the Rat

  1993cited by this paper
• The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis.

  1993cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis

  1992cited by this paper
• Liver dysfunction associated with long-term total parenteral nutrition in patients with massive bowel resection.

  1991cited by this paper
• Role of albumin in human physiology and pathophysiology.

  1991cited by this paper
• Liver function tests in patients receiving parenteral nutrition.

  1991cited by this paper
• Reviews: The Role of Albumin in Human Physiology and Pathophysiology, Part III: Albumin and Disease States

  1991cited by this paper
• Reviews: Role of Albumin in Human Physiology and Pathophysiology

  1991cited by this paper
• The role of albumin in human physiology and pathophysiology, Part III: Albumin and disease states.

  1991cited by this paper
• Abnormal liver function in malnourished patients receiving total parenteral nutrition: a prospective randomized study.

  1990cited by this paper
• Blood carnitine status after orthotopic liver transplantation in patients with end-stage liver disease.

  1989cited by this paper
• Increasing dextrose concentrations in total parenteral nutrition (TPN) causes alterations in hepatic morphology and plasma levels of insulin and glucagon in rats.

  1988cited by this paper
• Development of hepatic cholestasis and fibrosis in patients with massive loss of intestine supported by prolonged parenteral nutrition.

  1987cited by this paper
• Cutaneous application of safflower oil in preventing essential fatty acid deficiency in patients on home parenteral nutrition.

  1987cited by this paper
• Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels.

  1986cited by this paper
• Does long-term home parenteral nutrition in adult patients cause chronic liver disease?

  1985cited by this paper
• Hepatobiliary complications associated with TPN: an enigma.

  1985cited by this paper
• Gallbladder stasis: Consequence of long-term parenteral hyperalimentation and risk factor for cholelithiasis

  1983cited by this paper
• Gallbladder stasis: consequence of long-term parenteral hyperalimentation and risk factor for cholelithiasis.

  1983cited by this paper
• Choline deficiency associated with total parenteral nutrition.

  1980cited by this paper
• Incidence and mortality of hypoalbuminemic patients in hospitalized veterans.

  1980cited by this paper
• Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition.

  1980cited by this paper
• Liver function values in adults receiving total parenteral nutrition.

  1979cited by this paper
• Serum hepatic enzyme and bilirubin elevations during parenteral nutrition.

  1977cited by this paper
• B.C.G. vaccination and leukemia mortality.

  1970cited by this paper
• Long-term total parenteral nutrition with growth, development, and positive nitrogen balance.

  1968cited by this paper

• Parenteral Nutrition-Induced Liver Function Complications: Incidence, Risk Factors, and Prognosis

  2025cites this paper
• Intestinal-Failure-Associated Liver Disease: Beyond Parenteral Nutrition

  2025cites this paper
• Intestinal failure–associated liver disease in adult patients with chronic intestinal failure receiving home parenteral nutrition: A descriptive cohort study

  2025cites this paper
• Parenteral nutrition-associated liver injury: clinical relevance and mechanistic insights.

  2024cites this paper
• Intestinal failure-associated liver disease: Current challenges in screening, diagnosis, and parenteral nutrition considerations.

  2024cites this paper
• When all else fails: the colo-duodenal anastomosis

  2024cites this paper
• Investigation of parenteral nutrition-induced hepatotoxicity using human liver spheroid co-cultures

  2024cites this paper
• Parenteral nutrition results in peripheral ileal to hepatic circadian discordance in mice.

  2024cites this paper
• Improvement in Intestinal-Failure-Associated Liver Disease by Using Parenteral Fish Oil as Monotherapy: Case-Based Review of the Literature

  2023cites this paper
• ESPEN guideline on chronic intestinal failure in adults - Update 2023.

  2023cites this paper
• Organ allocation in pediatric abdominal transplant.

  2022cites this paper
• Use and Misuse of Parenteral Nutrition in Patients with Inflammatory Bowel Disease.

  2022cites this paper
• New insights into intestinal failure–associated liver disease in adults: A comprehensive review of the literature

  2021cites this paper
• ESPEN practical guideline: Clinical nutrition in chronic intestinal failure.

  2021cites this paper
• Long-Term Use of Mixed-Oil Lipid Emulsion in Soybean Oil-Intolerant Home Parenteral Nutrition Patients.

  2020cites this paper
• A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease.

  2020cites this paper
• Management of Intestinal Failure

  2020cites this paper
• Advanced liver function assessment in patients with intestinal failure on long-term parenteral nutrition.

  2020cites this paper
• Evaluation of Fibrosis in Intestinal Failure-Associated Liver Disease in the Sustain Registry.

  2020cites this paper
• Review of parenteral nutrition-associated liver disease

  2020cites this paper
• Surgical Metabolism: The Metabolic Care of the Surgical Patient

  2020cites this paper
• Soybean Oil Lipid Minimization for Prevention of Intestinal Failure Associated Liver Disease in Late Preterm and Term Infants with Gastro-Intestinal Surgical Disorders.

  2020cites this paper
• Fish Oil Emulsion Reduces Liver Injury and Liver transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.

  2020cites this paper
• Parenteral Nutrition–Associated Liver Disease in Adult Inpatients Receiving Commercial Premixed Parenteral Nutrition for More Than 2 Weeks

  2020cites this paper
• Intestinal Transplantation

  2019cites this paper
• Rifampicin, Not Vitamin E, Suppresses Parenteral Nutrition Associated Liver Disease Development through Pregnane X Receptor Pathway in Piglets.

  2019cites this paper
• New Lipid Strategies to Prevent/Treat Neonatal Cholestasis

  2019cites this paper
• Review article: diagnosis and management of intestinal failure‐associated liver disease in adults

  2019cites this paper
• Indications of Intestinal Transplantation.

  2019cites this paper
• The Long and Short of IT: intestinal failure-associated liver disease (IFALD) in adults—recommendations for early diagnosis and intestinal transplantation

  2019cites this paper
• Hepatobiliary Complications of Intestinal Failure and Home Parenteral Nutrition

  2019cites this paper
• Intestinal failure-associated liver disease in adult patients.

  2019cites this paper
• Visceral Transplantation: Current Trends and Long-Term Outcome

  2019cites this paper
• Intestinal failure‐associated liver disease: Risks and regression

  2018cites this paper
• Prevalence, Evolution, and Risk Factors for Advanced Liver Fibrosis in Adults Undergoing Intestinal Transplantation

  2018cites this paper
• A detailed guide to lipid therapy in intestinal failure.

  2018cites this paper
• Parenteral Nutrition: Indications, Access, and Complications.

  2018cites this paper
• Long‐Term Use of Mixed‐Oil Lipid Emulsion in Adult Home Parenteral Nutrition Patients: A Case Series

  2018cites this paper
• Enteral fish oil supplementation in the resolution of parenteral nutrition associated cholestasis

  2018cites this paper
• Visceral transplantation in patients with intestinal‐failure associated liver disease: Evolving indications, graft selection, and outcomes

  2018cites this paper
• Lipids in the intensive care unit: Recommendations from the ESPEN Expert Group.

  2017cites this paper
• The Differentiation of Intestinal-Failure-Associated Liver Disease from Nonalcoholic Fatty Liver and Nonalcoholic Steatohepatitis

  2017cites this paper
• Pre-emptive Intestinal Transplant: The Surgeon’s Point of View

  2017cites this paper
• Emergence of Mixed-Oil Fat Emulsions for Use in Parenteral Nutrition

  2017cites this paper
• Organ allocation and utilization in pediatric transplantation.

  2017cites this paper
• Prevalence and risk factors for complications in adult patients with short bowel syndrome receiving long-term home parenteral nutrition.

  2017influential citation
• Sub-acute toxicity assessment of Sapium ellipticum (Hochst) Pax ethanol leaf extract in Wistar rats

  2017cites this paper
• Choice of Allograft in Patients Requiring Intestinal Transplantation: A Critical Review

  2017cites this paper
• Short Bowel Syndrome and Intestinal Failure in Crohn's Disease

  2016cites this paper
• Clinical Outcomes of Pediatric Intestinal Failure Management after Implementation of a Multidisciplinary Intestinal Rehabilitation Program

  2016cites this paper
• Cholestasis in Preterm Infants.

  2016cites this paper
• ESPEN guidelines on chronic intestinal failure in adults.

  2016cites this paper
• Cholelithiasis and Nephrolithiasis

  2016cites this paper
• Home Parenteral Nutrition: Fat Emulsions and Potential Complications.

  2016cites this paper
• The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.

  2015cites this paper
• Complications hépatobiliaires associées à l’insuffisance intestinale chronique en nutrition parentérale de longue durée chez l’adulte : prévention et traitement

  2015cites this paper
• Transition of Decade in Short Bowel Syndrome in China: Yesterday, Today, and Tomorrow.

  2015cites this paper
• Outcome of pigs with short gut syndrome submitted to orthotopic intestinal transplantation.

  2015cites this paper
• Drug-Induced Liver Injury.

  2015cites this paper
• No Gut Syndrome: Near Total Enterectomy

  2015cites this paper
• Betaine: a potential agent for the treatment of hepatopathy associated with short bowel syndrome.

  2014cites this paper
• Liver Disease Secondary to Intestinal Failure

  2014cites this paper
• Short bowel syndrome: highlights of patient management, quality of life, and survival.

  2014cites this paper
• Liver disease in pediatric onset intestinal failure

  2014cites this paper
• Cholestasis in the Hospitalized Patient

  2014cites this paper
• Anti-Inflammatory and Anti-Fibrotic Profile of Fish Oil Emulsions Used in Parenteral Nutrition-Associated Liver Disease

  2014cites this paper
• Indications for intestinal transplantation: recognizing the scope and limits of total parenteral nutrition

  2013cites this paper
• Role of parenteral lipid emulsions in the preterm infant.

  2013cites this paper
• Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition.

  2013cites this paper
• Provision of a soy-based intravenous lipid emulsion at 1 g/kg/d does not prevent cholestasis in neonates.

  2013cites this paper
• Der Einfluss von TNF-α-Inhibitoren auf den Ischämie-/Reperfusionsschaden und assoziierte Inflammationsreaktionen in der Dünndarmtransplantation

  2013cites this paper
• Review article: the management of long‐term parenteral nutrition

  2013cites this paper
• Kurzdarmsyndrom und Darmversagen: Diagnostik und Therapie

  2013cites this paper
• Waitlist characteristics of patients at a single‐center intestinal and multivisceral transplant program

  2013cites this paper
• The role of total parenteral nutrition in inflammatory bowel disease: current aspects

  2013cites this paper
• Small bowel transplantation.

  2013cites this paper
• Key issues in addressing the clinical and humanistic burden of short bowel syndrome in the US

  2013cites this paper
• Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.

  2013cites this paper
• Facilitating Clinical Trials of Parenteral Lipid Strategies for the Prevention of Intestinal Failure Associated Liver Disease (IFALD) in Infants

  2013cites this paper
• THE EFFECT OF ALUMINUM ON HEPATIC BILIARY TRANSPORTERS AS A CONTRIBUTING FACTOR TO PARENTERAL NUTRITION INDUCED INTRAHEPATIC CHOLESTASIS

  2013cites this paper
• A radiologist's guide to small bowel and multivisceral transplantation.

  2013cites this paper
• Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN.

  2012cites this paper
• Cholestasis and growth in neonates with gastroschisis.

  2012cites this paper
• Approach to a patient with elevated serum alkaline phosphatase.

  2012cites this paper
• Current management of short bowel syndrome.

  2012cites this paper
• Australia's first liver–intestinal transplant

  2012cites this paper
• Preresection Obesity Increases the Risk of Hepatobiliary Complications in Short Bowel Syndrome

  2012cites this paper
• Canadian home parenteral nutrition (HPN) registry: validation and patient outcomes.

  2012cites this paper
• The Use of Fish Oil Lipid Emulsion in the Treatment of Intestinal Failure Associated Liver Disease (IFALD)

  2012cites this paper
• Chapter 55 – The Liver and Parenteral Nutrition

  2012cites this paper
• The prevention and treatment of intestinal failure-associated liver disease in neonates and children.

  2011cites this paper
• Intestinal transplantation: Current status and future directions

  2011cites this paper
• Complicaciones hepatobiliares asociadas a la Nutrición Parenteral Domiciliaria (NPD)

  2011cites this paper
• The Impact of MELD/PELD Revisions on the Mortality of Liver–Intestine Transplantation Candidates

  2011cites this paper
• Specialized nutrition support.

  2011cites this paper
• [Home-Based Parenteral Nutrition (HBPN)-associated hepatobiliary complications].

  2011cites this paper
• Radiation therapy increases the risk of hepatobiliary complications in short bowel syndrome.

  2011cites this paper
• Intestinal Failure–Associated Liver Disease

  2011cites this paper
• Home parenteral nutrition support for intestinal failure.

  2011cites this paper
• Clinical Assessment of Intestinal Failure in Adults

  2011cites this paper